APA (7th ed.) Citation

Martini, S., Salmoni, L., Palladino, R., Russo, A., Cuomo, N., Raddi, A., . . . Coppola, N. (2025). Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection. International Journal of Molecular Sciences, 26(18), 8881. https://doi.org/10.3390/ijms26188881

Chicago Style (17th ed.) Citation

Martini, Salvatore, et al. "Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection." International Journal of Molecular Sciences 26, no. 18 (2025): 8881. https://doi.org/10.3390/ijms26188881.

MLA (9th ed.) Citation

Martini, Salvatore, et al. "Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection." International Journal of Molecular Sciences, vol. 26, no. 18, 2025, p. 8881, https://doi.org/10.3390/ijms26188881.